Josh Kramer will be presenting in the upcoming IRCND conference on: O-GlcNAcase inhibion Reduces Neuroinflammaon and Modulates Metabolic Pathways in an Alzheimer’s Disease mouse model
Josh Kramer will be presenting in the upcoming IRCND conference on: O-GlcNAcase inhibion Reduces Neuroinflammaon and Modulates Metabolic Pathways in an Alzheimer’s Disease mouse model